← Back to Search

Surgery Techniques for Ulnar Nerve Entrapment

N/A
Recruiting
Led By Kevin Chung, MD, MS
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Clinical diagnosis or suspected diagnosis of isolated ulnar neuropathy at the elbow
Able to read, understand and complete the questionnaires in English
Must not have
Recurrent UNE after previous surgery
Participants with severe comorbid conditions that prohibit surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to determine which of two surgeries is more effective in treating ulnar neuropathy at the elbow and reducing symptoms.

Who is the study for?
This trial is for people with ulnar nerve entrapment at the elbow who have tried non-surgical treatments like night splinting. They must meet specific diagnostic criteria and be able to follow study procedures. It's not for those with previous elbow surgery, other neuropathies, or conditions that make surgery too risky.
What is being tested?
The study compares two surgeries: 'simple decompression' and 'subcutaneous anterior transposition,' to see which one better relieves symptoms of ulnar neuropathy at the elbow. Participants will be randomly assigned to one of these surgical options.
What are the potential side effects?
Potential side effects from both surgeries may include pain at the surgery site, infection risk, numbness or weakness in the hand or arm, and complications related to anesthesia.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have or might have a pinched nerve in my elbow.
Select...
I can read, understand, and fill out questionnaires in English.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My UNE has come back after surgery.
Select...
I cannot undergo surgery due to severe health conditions.
Select...
I had surgery for a broken elbow in the past.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Operative Surgical Procedures
Secondary study objectives
Complication rates for both surgical procedures assessed using a checklist
Difference in Grip Strength (unaffected hand - affected hand) measured by a Jamar dynamometer
Difference in Pinch Strength (unaffected hand - affected hand) as measured by a pinch gauge
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Subcutaneous anterior transpositionActive Control1 Intervention
Anterior transposition repositions the ulnar nerve, providing decompression and lengthening by moving the nerve anterior to the axis of elbow rotation
Group II: Simple decompressionActive Control1 Intervention
In-situ decompression releases only the compressive ligamentous structures overlying the ulnar nerve.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Ulnar Nerve Entrapment include decompression and transposition surgeries. Decompression involves relieving pressure on the ulnar nerve by removing any constrictive tissues or structures, which helps to restore normal nerve function and alleviate symptoms. Transposition surgery involves relocating the ulnar nerve to a position where it is less likely to be compressed or irritated, often moving it from behind the medial epicondyle to a more anterior position. These treatments are crucial for patients as they directly address the mechanical compression of the nerve, which is the primary cause of pain, numbness, and muscle weakness associated with Ulnar Nerve Entrapment. By alleviating this pressure, these surgical interventions can significantly improve nerve function and patient quality of life.

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,863 Previous Clinical Trials
6,441,195 Total Patients Enrolled
University of OklahomaOTHER
474 Previous Clinical Trials
93,316 Total Patients Enrolled
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
502 Previous Clinical Trials
1,089,640 Total Patients Enrolled
Curtis National Hand CenterUNKNOWN
Emory HealthcareOTHER
5 Previous Clinical Trials
1,487 Total Patients Enrolled
Ohio State UniversityOTHER
871 Previous Clinical Trials
655,354 Total Patients Enrolled
University of Pittsburgh Medical CenterOTHER
75 Previous Clinical Trials
76,565 Total Patients Enrolled
Norton HealthcareOTHER
16 Previous Clinical Trials
2,483 Total Patients Enrolled
OrthoCarolina Research Institute, Inc.OTHER
36 Previous Clinical Trials
5,668 Total Patients Enrolled
Wake Forest University Health SciencesOTHER
1,403 Previous Clinical Trials
2,477,557 Total Patients Enrolled

Media Library

Simple decompression Clinical Trial Eligibility Overview. Trial Name: NCT04254185 — N/A
Ulnar Nerve Entrapment Research Study Groups: Subcutaneous anterior transposition, Simple decompression
Ulnar Nerve Entrapment Clinical Trial 2023: Simple decompression Highlights & Side Effects. Trial Name: NCT04254185 — N/A
Simple decompression 2023 Treatment Timeline for Medical Study. Trial Name: NCT04254185 — N/A
~41 spots leftby Aug 2025